Atlanta-based EarliTec Diagnostics, with FDA-approved autism diagnostic tool, raised $21.5M in Series B funding led by Nexus NeuroTech Ventures and Venture Investors.
EarliTec Diagnostics, an Atlanta-based startup, raised $21.5M in a Series B round led by Nexus NeuroTech Ventures and Venture Investors. The company's FDA-approved system helps clinicians diagnose children as young as 16 months old with autism. The technology uses AI to track eye movements while children watch short videos, detecting differences in focus between those with and without autism.
April 06, 2024
3 Articles